Updates are available Correction dated 2019-11-14
Click to view Correction: https://doi.org/10.1038/s41586-019-1761-7
-
Authors
Aghajanian, Haig
Kimura, Toru
Rurik, Joel G.
Hancock, Aidan S.
Leibowitz, Michael S.
Li, Li
Scholler, John
Monslow, James
Lo, Albert
Han, Wei
Wang, Tao
Bedi, Kenneth
Morley, Michael P.
Linares Saldana, Ricardo A.
Bolar, Nikhita A.
McDaid, Kendra
Assenmacher, Charles-Antoine
Smith, Cheryl L.
Wirth, Dagmar
June, Carl H.
Margulies, Kenneth B.
Jain, Rajan
Puré, Ellen
Albelda, Steven M.
Epstein, Jonathan A.
- License Information
-
More Information
Article History
Received: 26 November 2018
Accepted: 8 August 2019
First Online: 11 September 2019
Change Date: 14 November 2019
Change Type: Correction
Change Details: An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: C.H.J., E.P. and S.M.A. are inventors (University of Pennsylvania, Wistar Institute) on a patent for a FAP CAR (US Utility Patent 9,365,641 issued 14 June 2016, WIPO Patent Application PCT/US2013/062717). H.A. and J.A.E. are inventors (University of Pennsylvania) on a patent for the use of CAR T therapy in heart disease (US Provisional Patent Application 62/563,323 filed 26 September 2017, WIPO Patent Application PCT/US2018/052605). C.H.J. is a scientific founder and has equity in Tmunity Therapeutics, a biotech dedicated to developing engineered T cells for therapy of cancer, infections and autoimmunity, reports grants from Novartis and Tmunity Therapeutics and is on the scientific advisory boards of Immune Design, Viracta Therapeutics, Carisma Therapeutics and Cabaletta Bio.
